# Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.

> **NCT05027672** · PHASE2 · UNKNOWN · sponsor: **Ministerio de Salud de Ciudad Autónoma de Buenos Aires** · enrollment: 348 (actual)

## Conditions studied

- COVID-19 Vaccines

## Interventions

- **DRUG:** Gam-COVID-Vac (rAd26) / Gam-COVID-Vac (rAd5)

## Key facts

- **NCT ID:** NCT05027672
- **Lead sponsor:** Ministerio de Salud de Ciudad Autónoma de Buenos Aires
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-30
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-09-06
- **Target enrollment:** 348 (ACTUAL)
- **Last updated:** 2021-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05027672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05027672, "Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05027672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*